StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
FXI.ST$0.10+1.00%
Fair $0.10+0.0%

FXI.ST

FXI.ST

Financial Services / Asset ManagementStockholm

$0.10

+0.00 (+1.00%)

Fairly Valued+0.0%Fair Value $0.10Fund rank 22/100 · Data gapFallback financials|
SA 6/F
F-Score: 4/9
Low Profitability

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 0.0/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 10/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

6/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. ROE is -21.2%, below the 5% threshold
Thesis & Journal · FXI.STLocal privado en este navegador · FXI.ST
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-21.2%

↓

Gross Margin

-1103.9%

↓

Debt/Equity

N/A

•
52-Week Range$0
$0$0

TradingView lightweight chart

FXI.ST price, volumen y niveles de valoración

Último $0.101Periodo -96.0%
Fair value: $0.101

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-44.6%

FCF CAGR

—

FCF margin

461.8%

FCF / Net income

-0.12x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $102000.0 · net income $-4.0M · FCF $471000.0

2022-FY → 2025-FY

Gross margin

-1103.9%-1183.8% pts

Operating margin

-5161.8%-4750.4% pts

Net margin

-3898.0%-3668.3% pts

FCF margin

461.8%+874.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$102000.00$102000.00$-6.7M$303262.00$600998.00
Net Income$-4.0M$-4.0M$-15.9M$-12.0M$-1.4M
EBITDA$-2.7M$-2.7M$-13.6M$-11.5M$-878116.00
EPS——-0.13-0.21-0.02
Gross Margin-1103.9%-1103.9%118.1%-34.3%79.9%
Operating Margin-5161.8%-5161.8%181.6%-1115.9%-411.4%
Net Margin-3898.0%-3898.0%237.8%-3948.5%-229.7%
Balance Sheet
Current Ratio0.250.25———
Cash Flow
Free Cash Flow$471000.00$471000.00$-5.5M$-1.7M$-2.5M
Returns
ROE-21.2%-21.2%-66.6%-50.9%-3.9%
Valuation
P/B0.480.480.441.111.27
Growth & Yield
Revenue Growth101.5%101.5%-2298.1%-49.5%—
EPS Growth——38.1%-767.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -26.8%

Total return

-26.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.13 → n/d

Residual

-26.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-26.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.